| Stage | LAD | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.9B | 100.00% | $8.0B | 100.00% | LAD ×1.24 |
| Gross profit | $1.5B | 15.04% | $1.5B | 18.92% | CVNA +3.9pp |
| Operating income | $420M | 4.22% | $714M | 8.88% | CVNA +4.7pp |
| Pre-tax income | $391M | 3.93% | $552M | 6.87% | CVNA +2.9pp |
| Net income | $293M | 2.94% | $483M | 6.01% | CVNA +3.1pp |
| Stage | LAD | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $9.9B100.00% | $8.0B100.00% | LAD ×1.24 |
| Gross profit | 15.04%$1.5B | 18.92%$1.5B | CVNA +3.9pp |
| Operating income | 4.22%$420M | 8.88%$714M | CVNA +4.7pp |
| Pre-tax income | 3.93%$391M | 6.87%$552M | CVNA +2.9pp |
| Net income |
| 2.94%$293M |
| 6.01%$483M |
| CVNA +3.1pp |
No shared counterparties.